🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share our publication on the survival benefits associated with skin toxicities in the setting of immunotherapy. Big thanks to Kimberly Tang, Dr. Shawn Kwatra, Kerry Reynolds, and the rest of the team. ja.ma/3tuso2C via JAMA Dermatology part of JAMA Network

Very excited to share our publication in npj Precision Oncology on machine learning approaches to predict early-stage melanoma recurrence, led by the amazing ⁦Guihong WAN⁩ and ⁦Nga Nguyen⁩. nature.com/articles/s4169…

Excited to share our publication on the prognostic benefits of cutaneous immune-related adverse events, validating our previous population-level findings. Special thanks to Zhang Shijia, Kimberly Tang, Guihong WAN, and the rest of the team. #dermtwitter #MedTwitter

Excited to share our JAMA Dermatology viewpoint bitly.ws/3fSDp examining immunotherapy in localized melanoma. Big congrats to Hannah Rashdan in my lab for leading the piece, which was also a hot topic @ the most recent Melanoma Research meeting! Thx to Ade Adamson, MD MPP for his collab.

Very excited to have matched into Dermatology at Vanderbilt!! Vanderbilt Health Big thank you to my family, friends, and mentors, especially Eugene Semenov, MD for the endless guidance and support!! #Match2024 #dermtwitter

Very excited to share our Delphi consensus guidelines to diagnosing dermatologic immunotherapy toxicites. Incredible team effort from more than 30 experts, including Steven Chen 陳持威, MD, MPH, MHPEd Kerry Reynolds, Jarushka Naidoo, and Nicole LeBoeuf.

Extremely proud of the team, especially Guihong WAN, Sara Khattab, MD, and Wenxin Elmon Chen for our The Lancet Oncology study on multi-organ toxicities from checkpoint blockade, providing a roadmap for prognosticating outcomes via the lens of immunotherapy toxicities: tinyurl.com/yc3t7amf